Table 2.
Cases | Controls | Unadjusted | Adjustedab | |||||
---|---|---|---|---|---|---|---|---|
n = 2238 | % | n = 8645 | % | OR | 95% CI | OR | 95% CI | |
BZDs | ||||||||
Current users | 672 | 30.0 | 2144 | 24.8 | 1.18 | 1.06–1.32 | 1.32 | 1.17–1.50 |
Indeterminate users | 160 | 7.2 | 879 | 10.2 | 0.69 | 0.57–0.83 | 0.75 | 0.62–0.91 |
Former users | 295 | 13.2 | 1519 | 17.6 | 0.73 | 0.63–0.84 | 0.74 | 0.64–0.86 |
Non-users | 1111 | 49.6 | 4103 | 47.5 | 1 | 1 | ||
Z-drugs | ||||||||
Current users | 224 | 10.0 | 721 | 8.3 | 1.23 | 1.05–1.45 | 1.24 | 1.05–1.48 |
Indeterminate users | 59 | 2.6 | 263 | 3.0 | 0.89 | 0.67–1.19 | 0.87 | 0.64–1.18 |
Former users | 141 | 6.3 | 572 | 6.6 | 0.98 | 0.81–1.18 | 0.96 | 0.78–1.17 |
Non- users | 1814 | 81.1 | 7089 | 82.0 | 1 | 1 |
aAdjusted for dementia, Parkinson’s disease, cerebrovascular disease, diabetes, hypertension, ischemia heart disease, antipsychotics, antidepressants, anticonvulsants, thiazide diuretics, opioids, Charlson comorbidity index, and number of outpatient services in the 180 days before the index date
bSignificant results (p<0.05) are in italicize